| Neuroprotection by group I mGlu receptors in a rat hippocampal slice model of cerebral ischemia is associated with the PI3K–Akt signaling pathway: A novel postconditioning … T Scartabelli, E Gerace, E Landucci, F Moroni, DE Pellegrini-Giampietro Neuropharmacology 55 (4), 509-516, 2008 | 97 | 2008 |
| Pharmacological effects of 3‐iodothyronamine (T1AM) in mice include facilitation of memory acquisition and retention and reduction of pain threshold ME Manni, G De Siena, A Saba, M Marchini, E Landucci, E Gerace, ... British journal of pharmacology 168 (2), 354-362, 2013 | 79 | 2013 |
| Ischemic neuroprotection by TRPV1 receptor-induced hypothermia M Muzzi, R Felici, L Cavone, E Gerace, A Minassi, G Appendino, F Moroni, ... Journal of Cerebral Blood Flow & Metabolism 32 (6), 978-982, 2012 | 64 | 2012 |
| Selective PARP‐2 inhibitors increase apoptosis in hippocampal slices but protect cortical cells in models of post‐ischaemic brain damage F Moroni, L Formentini, E Gerace, E Camaioni, DE Pellegrini‐Giampietro, ... British journal of pharmacology 157 (5), 854-862, 2009 | 53 | 2009 |
| Neuroprotective effects of topiramate and memantine in combination with hypothermia in hypoxic-ischemic brain injury in vitro and in vivo E Landucci, L Filippi, E Gerace, S Catarzi, R Guerrini, ... Neuroscience Letters 668, 103-107, 2018 | 51 | 2018 |
| PARP-1 activation causes neuronal death in the hippocampal CA1 region by increasing the expression of Ca2+-permeable AMPA receptors E Gerace, A Masi, F Resta, R Felici, E Landucci, T Mello, ... Neurobiology of disease 70, 43-52, 2014 | 50 | 2014 |
| Prokineticins are neuroprotective in models of cerebral ischemia and ischemic tolerance in vitro E Landucci, R Lattanzi, E Gerace, T Scartabelli, G Balboni, L Negri, ... Neuropharmacology 108, 39-48, 2016 | 45 | 2016 |
| Caspase inhibition augments Dichlorvos-induced dopaminergic neuronal cell death by increasing ROS production and PARP1 activation WY Wani, A Sunkaria, DR Sharma, RJL Kandimalla, A Kaushal, E Gerace, ... Neuroscience 258, 1-15, 2014 | 44 | 2014 |
| Rat hippocampal slice culture models for the evaluation of neuroprotective agents E Gerace, E Landucci, T Scartabelli, F Moroni, DE Pellegrini-Giampietro Neurotrophic Factors: Methods and Protocols, 343-354, 2012 | 41 | 2012 |
| CB1 receptors and post-ischemic brain damage: studies on the toxic and neuroprotective effects of cannabinoids in rat organotypic hippocampal slices E Landucci, T Scartabelli, E Gerace, F Moroni, DE Pellegrini-Giampietro Neuropharmacology 60 (4), 674-682, 2011 | 36 | 2011 |
| Poly (ADP‐ribose) polymerase inhibition with HYDAMTIQ reduces allergen‐induced asthma‐like reaction, bronchial hyper‐reactivity and airway remodelling L Lucarini, A Pini, E Gerace, R Pellicciari, E Masini, F Moroni Journal of Cellular and Molecular Medicine 18 (3), 468-479, 2014 | 35 | 2014 |
| Ethanol toxicity during brain development: alterations of excitatory synaptic transmission in immature organotypic hippocampal slice cultures E Gerace, E Landucci, A Totti, D Bani, D Guasti, R Baronti, F Moroni, ... Alcoholism: Clinical and Experimental Research 40 (4), 706-716, 2016 | 28 | 2016 |
| Mild activation of poly (ADP‐ribose) polymerase (PARP) is neuroprotective in rat hippocampal slice models of ischemic tolerance E Gerace, T Scartabelli, L Formentini, E Landucci, F Moroni, A Chiarugi, ... European Journal of Neuroscience 36 (1), 1993-2005, 2012 | 28 | 2012 |
| Biochemical and electrophysiological modification of amyloid transthyretin on cardiomyocytes L Sartiani, M Bucciantini, V Spinelli, M Leri, A Natalello, D Nosi, ... Biophysical Journal 111 (9), 2024-2038, 2016 | 26 | 2016 |
| Effect of Class II HDAC inhibition on glutamate transporter expression and survival in SOD1-ALS mice A Lapucci, L Cavone, D Buonvicino, R Felici, E Gerace, C Zwergel, ... Neuroscience Letters 656, 120-125, 2017 | 24 | 2017 |
| Involvement of endocannabinoid signaling in the neuroprotective effects of subtype 1 metabotropic glutamate receptor antagonists in models of cerebral ischemia E Landucci, F Boscia, E Gerace, T Scartabelli, A Cozzi, F Moroni, ... International Review of Neurobiology 85, 337-350, 2009 | 24 | 2009 |
| Dexpramipexole improves bioenergetics and outcome in experimental stroke M Muzzi, E Gerace, D Buonvicino, E Coppi, F Resta, L Formentini, ... British journal of pharmacology 175 (2), 272-283, 2018 | 23 | 2018 |
| Neuroprotective effects of mGluR5 activation through the PI3K/Akt pathway and the molecular switch of AMPA receptors D Cavallo, E Landucci, E Gerace, D Lana, F Ugolini, JM Henley, ... Neuropharmacology 162, 107810, 2020 | 19 | 2020 |
| Interplay between histone acetylation/deacetylation and poly (ADP-ribosyl) ation in the development of ischemic tolerance in vitro E Gerace, E Landucci, T Scartabelli, F Moroni, A Chiarugi, ... Neuropharmacology 92, 125-134, 2015 | 19 | 2015 |
| Poly (ADP-ribose) polymerase 1 (PARP-1) activation and Ca2+ permeable α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) channels in post-ischemic brain damage: New … E Gerace, D E Pellegrini-Giampietro, F Moroni, G Mannaioni CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2015 | 18 | 2015 |
DE Pellegrini-GiampietroUniversità degli Studi di FirenzeEmail verificata su unifi.it
